{
  "url": "https://openlegislation.uk/human-medicines-amendment-modular-manufacture-and-point-of-care-regulations-2025/regulation-34",
  "json_url": "https://openlegislation.uk/human-medicines-amendment-modular-manufacture-and-point-of-care-regulations-2025/regulation-34.json",
  "legislation": "uksi/2025/87",
  "legislation_title": "The Human Medicines (Amendment) (Modular Manufacture and Point of Care) Regulations 2025",
  "legislation_url": "https://openlegislation.uk/human-medicines-amendment-modular-manufacture-and-point-of-care-regulations-2025",
  "path": "regulation/34",
  "kind": "regulation",
  "number": "34",
  "heading": "Amendment of Schedule 3",
  "text": "(1) Schedule 3 (applications for licences under Part 3) is amended as follows.\n(2) In paragraph 1(2)—\n(a) in sub-paragraph (c), at the beginning insert “except where the operations will relate to an MM medicinal product or a POC medicinal product,”;\n(b) after sub-paragraph (c) insert—\n“(ca) where the application relates to an MM medicinal product, the address of the MM control site;\n(cb) where the application relates to a POC medicinal product, the address of the POC control site;”; and\n(c) in sub-paragraph (d), after “paragraph (c)” insert “, (ca) or (cb)”.\n(3) In paragraph 1(3), after sub-paragraph (b) insert—\n“(ba) a statement of whether any of the medicinal products to be manufactured or assembled are MM medicinal products or POC medicinal products;”.\n(4) After paragraph 1 insert—\n“Manufacturer’s licences (MM)\n1A. (1) This paragraph applies to an application for a manufacturer’s licence relating to MM medicinal products.\n(2) In addition to the requirements in paragraph 1, the application must be accompanied by a dossier for each MM medicinal product to which the application relates, which includes, as a minimum, the following—\n(a) a description and means of identification of each modular unit at which manufacture or assembly of the MM medicinal product is to take place;\n(b) the location of each unit at which manufacturing or assembly of the MM medicinal product is to take place;\n(c) the location of each site at which operations related to the manufacture or assembly of the MM medicinal product are to take place;\n(d) a description of the process by which the licence holder will approve new modular units;\n(e) a description of the processes by which the licence holder will initiate, suspend and cease manufacturing or assembly of the product at a modular unit;\n(f) a description of the manufacturing, assembly and product release processes to take place at each modular unit;\n(g) a description of the arrangements for supervision and control by the licence holder of the manufacture or assembly operations at each modular unit;\n(h) a description of the arrangements for reporting of suspected adverse reactions from modular units to the MM control site;\n(i) the name and contact details of the person at the MM control site who is to be contacted in respect of manufacturing or assembly operations under the licence;\n(j) the name and contact details of the person to be contacted in respect of manufacturing or assembly operations at each modular unit;\n(k) the name and contact details of the person at the MM control site who is to be contacted in respect of quality operations under the licence;\n(l) the name and contact details of the person to be contacted in respect of quality operations at each modular unit; and\n(m) a description of the processes by which the licence holder will review and amend the MM master file for the product.\nManufacturer’s licence (POC)\n1B. (1) This paragraph applies to an application for a manufacturer’s licence relating to POC medicinal products.\n(2) In addition to the requirements in paragraph 1, the application must be accompanied by a dossier for each POC medicinal product to which the application relates, which includes, as a minimum, the following—\n(a) the location of each site at which manufacturing or assembly of the POC medicinal product is to take place;\n(b) the location of each site at which operations related to the manufacture or assembly of the POC medicinal product are to take place;\n(c) a description of the process by which the licence holder will approve new POC sites;\n(d) a description of the processes by which the licence holder will suspend and cease manufacturing or assembly of the POC medicinal product at a POC site;\n(e) a description of the manufacturing, assembly and product release processes to take place at each POC site;\n(f) a description of the arrangements for supervision and control by the licence holder of the manufacture or assembly operations at each POC site;\n(g) a description of the arrangements for reporting of suspected adverse reactions from POC sites to the POC control site;\n(h) the name and contact details of the person at the POC control site who is to be contacted in respect of manufacturing or assembly operations under the licence;\n(i) the name and contact details of the person to be contacted in respect of manufacturing or assembly operations at each POC site;\n(j) the name and contact details of the person at the POC control site who is to be contacted in respect of quality operations under the licence;\n(k) the name and contact details of the person who is to be contacted in respect of quality operations at each POC site; and\n(l) a description of the processes by which the licence holder will review and amend the POC master file for the product.”.",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "footnote",
      "label": "f1",
      "text": "There are amendments but none is relevant."
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2025/87/regulation/34",
    "retrieved_at": "2026-10-28T21:21:13.963585+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}